Shilpa Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve unaudited financial results ....
SHILPAMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shilpa Medicare has informed the stock exchanges that its Board of Directors will meet on Wednesday, 13 August 2025. The key agenda is to consider and approve the unaudited financial results for the quarter ended 30 June 2025 (Q1 FY26). The company has also confirmed that the trading window for insiders has been closed from 1 July 2025 and will remain closed until 48 hours after the results are declared, i.e. until 15 August 2025. The intimation is filed under Regulation 29 of SEBI LODR Regulations, 2015. No financial figures or business commentary are provided in this filing.
This is a routine procedural intimation with no immediate impact on the stock price. Investors should watch for the actual Q1 FY26 results on 13 August 2025, which may drive sentiment depending on revenue, margins, and profit performance versus expectations.